Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.57 |
| ▸ | TACR1 | P25103 | 3/20 | 0.51 |
| ▸ | CTSL | P07711 | 3/20 | 0.50 |
| ▸ | CTSB | P07858 | 2/20 | 0.50 |
| ▸ | CTSS | P25774 | 2/20 | 0.50 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | PLAT | P00750 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8198038 | 0.90 | CTRB1 (0.58) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL9619639 | 0.82 | ATM (0.54) | CTRB1CTSLCTSBCTSSCTSK | |
| SCHEMBL14927646 | 0.81 | CTRB1 (0.61) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL10716393 | 0.80 | ALDH1A1 (0.50) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL13866599 | 0.80 | CTRB1 (0.59) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL3864222 | 0.80 | CTRB1 (0.59) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL3893048 | 0.80 | CTRB1 (0.59) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL9074306 | 0.79 | CTRB1 (0.58) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL28141917 | 0.79 | CTRB1 (0.58) | CTRB1TACR1CTSLCTSBCTSS | |
| SCHEMBL8198203 | 0.79 | CTRB1 (0.58) | CTRB1TACR1CTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0413762-B1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN INT INC (US) | 2000-07-12 | — | — | EP | disclosed |
| EP-0413762-A4 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | — | 1992-01-15 | — | — | EP | disclosed |
| EP-0413762-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INCORPORATED (US) | 1991-02-27 | — | — | EP | disclosed |
| WO-1989010961-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-11-16 | — | — | WO | disclosed |